Nonalcoholic Steatohepatitis
📧 Sign up to get email alerts when something new happens for Nonalcoholic Steatohepatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-07-25Clinical Trial Update: Digital Therapeutic Lifestyle Intervention Program for Patients With MASLD [NA]
A clinical trial evaluating a digital therapeutic lifestyle intervention for metabolic dysfunction-associated steatotic liver disease (MASLD…
-
CLINICAL_TRIALS withdrawal · 2025-05-15Clinical Trial Update: A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASH and F2/F3 Fibrosis [Phase 3]
Phase 3 study evaluating denifanstat for metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-09-27Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 in Adults With NASH [Phase 2]
A Phase 2 clinical trial evaluating ASC41 for nonalcoholic steatohepatitis (NASH) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-05-28Clinical Trial Update: Vitamin E Versus Vitamin E Plus Pentoxiphyllin in Patients With Nonalcoholic Steatohepatitis: A Prospective Randomized Clinical Trial [NA]
The prospective randomized trial comparing Vitamin E alone to Vitamin E plus pentoxifylline for nonalcoholic steatohepatitis has been withdr…
-
CLINICAL_TRIALS withdrawal · 2012-12-06Clinical Trial Update: Safety and Efficacy Study of IMM 124-E (Bovine Colostrum) for Patients With Nonalcoholic Steatohepatitis [Phase 2]
A Phase 2 safety and efficacy trial of IMM 124-E (bovine colostrum) for nonalcoholic steatohepatitis has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.